True North Advisors, LLC Johnson & Johnson Transaction History

True North Advisors, LLC

$378 Million
Q3 2024

A detailed history of True North Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, True North Advisors, LLC holds 8,793 shares of JNJ stock, worth $1.36 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

8,793

Previous 8,854 0.69%

Holding current value

$1.36 Million

Previous $1.29 Million 10.05%

% of portfolio

0.38%

Previous 0.35%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$145.48 - $167.38 $8,874 - $10,210	-61 Reduced 0.69%	8,793 $1.42 Million
Q2 2024 Aug 12, 2024	BUY	$144.38 - $157.78 $41,003 - $44,809	284 Added 3.31%	8,854 $1.29 Million
Q1 2024 Apr 12, 2024	SELL	$155.22 - $162.74 $1.08 Million - $1.13 Million	-6,941 Reduced 44.75%	8,570 $1.36 Million
Q4 2023 Jan 22, 2024	SELL	$145.6 - $158.88 $372,444 - $406,415	-2,558 Reduced 14.16%	15,511 $2.43 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $235,182 - $263,464	-1,510 Reduced 7.71%	18,069 $2.81 Million
Q2 2023 Aug 10, 2023	SELL	$154.35 - $166.11 $139,995 - $150,661	-907 Reduced 4.43%	19,579 $3.24 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $25,829 - $30,824	171 Added 0.84%	20,486 $3.18 Million
Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $59,754 - $67,061	-373 Reduced 1.8%	20,315 $3.59 Million
Q3 2022 Nov 10, 2022	SELL	$161.33 - $179.52 $162,459 - $180,776	-1,007 Reduced 4.64%	20,688 $3.38 Million
Q2 2022 Jul 28, 2022	BUY	$168.19 - $186.01 $481,696 - $532,732	2,864 Added 15.21%	21,695 $3.85 Million
Q1 2022 May 12, 2022	SELL	$158.14 - $179.59 $3.32 Million - $3.77 Million	-20,969 Reduced 52.69%	18,831 $3.34 Million
Q4 2021 Feb 11, 2022	BUY	$155.93 - $173.01 $197,407 - $219,030	1,266 Added 3.29%	39,800 $6.81 Million
Q3 2021 Jun 07, 2022	BUY	$161.5 - $179.47 $112,404 - $124,911	696 Added 1.84%	38,534 $6.22 Million
Q2 2021 Jun 07, 2022	SELL	$159.48 - $171.07 $79,740 - $85,535	-500 Reduced 1.3%	37,838 $6.23 Million
Q1 2021 Jun 07, 2022	SELL	$153.07 - $170.48 $9,490 - $10,569	-62 Reduced 0.16%	38,338 $6.3 Million
Q4 2020 May 20, 2022	SELL	$137.11 - $157.38 $314,530 - $361,029	-2,294 Reduced 5.64%	38,400 $6.04 Million
Q3 2020 May 20, 2022	BUY	$140.38 - $153.83 $16,705 - $18,305	119 Added 0.29%	40,694 $6.06 Million
Q2 2020 May 20, 2022	BUY	$128.81 - $155.51 $12,623 - $15,239	98 Added 0.24%	40,575 $5.71 Million
Q1 2020 May 12, 2022	SELL	$111.14 - $153.99 $32,230 - $44,657	-290 Reduced 0.71%	40,477 $5.31 Million
Q4 2019 May 12, 2022	BUY	$127.5 - $146.44 $5.2 Million - $5.97 Million	40,767 New	40,767 $5.95 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of True North Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True North Advisors, LLC with notifications on news.

Account

True North Advisors, LLC Johnson & Johnson Transaction History